Colorectal cancer (CRC) has a strong familial component which extends to discordant cancers (ie non-CRC tumors). This is best seen in cancer syndromes such as hereditary non-polyposis colorectal cancer (HNPCC) which predisposes to several tumor types. Population-based family studies have also found discordant associations for CRC but they have included cancers which manifest in HNPCC, and there is no convincing evidence of discordant associations beyond the known syndromes. We address familial associations of non-CRC tumors with CRC using the resources of the Swedish Family-Cancer Database and applying a powerful approach of assessing familial relative risks in families of increasing numbers of patients with discordant cancers. Among 1.8 mi...
The familial occurrence of tumors has been investigated in 389 subjects with colorectal cancer by re...
Pinpointing heritability factors is fundamental for the prevention and early detection of cancer. Up...
AIMS: Cancer syndromes manifest at many sites albeit with variable penetrance. Genome-wide associati...
Colorectal cancer (CRC) has a strong familial component which extends to discordant cancers (ie non-...
Colorectal cancer (CRC) has a strong familial component which extends to discordant cancers (ie non-...
BACKGROUND: Many studies have indicated that colon and rectal cancers differ in etiology and histolo...
BACKGROUND: Increasing number of individuals will have first-degree relatives (FDRs) diagnosed with ...
The clinical data of 2 population-based registries, located in areas with different incidence rates ...
A family history is an identified risk factor for colorectal cancer (CRC). However, it is not known ...
Hereditary non-polyposis colorectal cancer (HNPCC) is an autosomal dominant disorder characterized b...
Relatives of cancer patients are at an increased risk of the same (concordant) cancer but whether th...
Familial risks of breast cancer (BC) are well established but whether BC clusters with other, i.e. d...
Background: About 15%-20% of colorectal cancers (CRCs) are familial. While a fraction of these arise...
Colorectal cancer (CRC) is one of the most common cancers in the Western world and in about 30% here...
Approximately 40% of colorectal cancer (CRC) families with a diagnosis of hereditary nonpolyposis CR...
The familial occurrence of tumors has been investigated in 389 subjects with colorectal cancer by re...
Pinpointing heritability factors is fundamental for the prevention and early detection of cancer. Up...
AIMS: Cancer syndromes manifest at many sites albeit with variable penetrance. Genome-wide associati...
Colorectal cancer (CRC) has a strong familial component which extends to discordant cancers (ie non-...
Colorectal cancer (CRC) has a strong familial component which extends to discordant cancers (ie non-...
BACKGROUND: Many studies have indicated that colon and rectal cancers differ in etiology and histolo...
BACKGROUND: Increasing number of individuals will have first-degree relatives (FDRs) diagnosed with ...
The clinical data of 2 population-based registries, located in areas with different incidence rates ...
A family history is an identified risk factor for colorectal cancer (CRC). However, it is not known ...
Hereditary non-polyposis colorectal cancer (HNPCC) is an autosomal dominant disorder characterized b...
Relatives of cancer patients are at an increased risk of the same (concordant) cancer but whether th...
Familial risks of breast cancer (BC) are well established but whether BC clusters with other, i.e. d...
Background: About 15%-20% of colorectal cancers (CRCs) are familial. While a fraction of these arise...
Colorectal cancer (CRC) is one of the most common cancers in the Western world and in about 30% here...
Approximately 40% of colorectal cancer (CRC) families with a diagnosis of hereditary nonpolyposis CR...
The familial occurrence of tumors has been investigated in 389 subjects with colorectal cancer by re...
Pinpointing heritability factors is fundamental for the prevention and early detection of cancer. Up...
AIMS: Cancer syndromes manifest at many sites albeit with variable penetrance. Genome-wide associati...